Nvidia and Microsoft Partner to Accelerate AI Innovation in Healthcare at HLTH Conference

Nvidia Joins Big Tech Hyperscalers At HLTH Conference, Partners With Microsoft To Drive AI Innovations - NVIDIA (NASDAQ:NVDA)

Nvidia and Microsoft teamed up at HLTH to support AI startups in healthcare with cloud credits, software, and technical aid. Tech giants like Nvidia Corp NVDA, Alphabet Inc GOOGL GOOG Google, and Microsoft Corp MSFT descended in Las Vegas this week to showcase artificial intelligence (AI) tools they claim can significantly reduce the administrative burden on healthcare professionals. The HLTH healthcare technology conference, expected to attract over 12,000 industry leaders, kicked off Sunday with AI-powered solutions designed to streamline documentation and patient care taking center stage, CNBC reported. Tech companies like Google and Microsoft see this as an opportunity to deploy AI to ease the strain on healthcare systems, a sector that could reach $6.8 trillion in spending by the end of the decade. Also Read: Microsoft, Salesforce Battle Heats Up As AI Agent Technology Takes Center Stage Microsoft and Nvidia are expanding their partnership to accelerate innovation for AI startups in the healthcare and life sciences. They announced during the HLTH healthcare innovation conference, where both companies revealed plans to support startups with cloud credits, AI software, and technical assistance to advance their work in areas like digital health. The initiative will leverage Microsoft's Azure cloud platform and Nvidia's AI capabilities to provide startups with cutting-edge tools. The collaboration aims to broaden the reach of AI-driven healthcare solutions by connecting the Nvidia Inception program with Microsoft for Startups. Nvidia will contribute its AI expertise, including 10,000 inference credits for using GPU-optimized models and access to the full suite of Nvidia Clara platforms specialized in healthcare and life sciences. Startups will also have early access to Nvidia's healthcare offerings and opportunities to connect with investors and industry partners. Microsoft will provide up to $150,000 in Azure credits and $200,000 in business tools to each participating startup, along with access to the company's Pegasus Program, which offers go-to-market support. Both companies will offer technical workshops to help startups develop applications using Nvidia's technology stack on Azure. The first phase of the partnership will focus on companies working in digital health and life sciences, with plans to extend the initiative to startups in other industries in the future. Both companies utilize Nvidia GPUs and Azure's HIPAA-compliant cloud environment to ensure security and privacy in their AI-driven solutions. Also on Monday, Nvidia revealed its collaboration with Aidoc, a startup that provides AI solutions for healthcare organizations to enhance workflows, improve data precision, and boost patient care. Together, they will develop a framework called "Blueprint for Resilient Integration and Deployment of Guided Excellence" (BRIDGE) to speed up AI implementation within the healthcare sector. Bank of America's Vivek Arya called Nvidia a "generational opportunity" due to its strong market dominance in the AI chip market. He noted that Nvidia could access a $400 billion market by 2024. Beth Kindig of I/O Fund expects Nvidia to reach a $10 trillion valuation by 2025 courtesy of its Blackwell chips. Price Action: NVDA stock is up 3.19% at $142.20 at last check Monday. Image via Shutterstock Also Read: IBM Expands Open-Source AI with Granite 3.0, Empowering Enterprise Flexibility This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors. Market News and Data brought to you by Benzinga APIs

Nvidia Partners With Startup Aidoc To Accelerate Healthcare AI Adoption - NVIDIA (NASDAQ:NVDA)

The BRIDGE guideline aims to establish a foundation aligned with industry frameworks like MONAI, which will serve as the blueprint. Nvidia Corp NVDA announced that it will partner with Aidoc, a startup that offers healthcare organizations artificial intelligence (AI) tools to improve workflows, data accuracy, and overall patient care. The companies will work on a new framework, "Blueprint for Resilient Integration and Deployment of Guided Excellence" (BRIDGE), a guideline that aims to accelerate AI adoption across the healthcare industry. Also Read: Microsoft Unveils Health Care AI Tools To Help Analyze Biomedical Data. The guideline, scheduled for release in early 2025, will introduce a comprehensive, evidence-based framework for more effectively integrating AI into clinical workflows. It aims to enable healthcare organizations to accelerate AI innovation with increased confidence. The guideline will outline strategies for healthcare systems to fully leverage AI's potential in enhancing patient outcomes. Although more than 900 FDA-cleared AI tools for medical imaging have been approved, healthcare systems still face fragmentation, operational inefficiencies, and scalability challenges. The BRIDGE guideline will offer a vendor-neutral, all-encompassing roadmap to tackle these issues, empowering providers to realize AI's benefits fully. "AI holds the potential to revolutionize patient care, but its progress has been stalled by fragmented systems and the inability to scale effectively," said Demetri Giannikopoulos, Chief Transformation Officer, Aidoc. "The BRIDGE guideline will focus on breaking down these barriers, offering a powerful, evidence-based framework that health systems can rely on not just adopt AI but to help scale it across their operations. This will drive both operational efficiency and significantly better outcomes for patients and clinicians alike." The BRIDGE guideline aims to establish a foundation aligned with industry frameworks like MONAI, which will serve as the blueprint for the medical AI enterprise platform. MONAI, co-founded in 2019 by academia and industry leaders, including NVIDIA, offers essential tools for developing, validating, and deploying medical AI. With over three million downloads and active use in FDA-approved software-as-medical-device applications, MONAI's emphasis on standardization, interoperability, and scalability is crucial to driving transformative healthcare solutions. Price Action: NVDA stock is up 0.32% at $138.32 at last check Monday. Read Next: Disney's Leadership Shift: James Gorman Named As Chairman, CEO Search Underway. Photo by PopTika on Shutterstock Market News and Data brought to you by Benzinga APIs